S Bank Fund Management Ltd raised its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 25.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 52,330 shares of the conglomerate’s stock after buying an additional 10,580 shares during the quarter. Danaher comprises 1.6% of S Bank Fund Management Ltd’s investment portfolio, making the stock its 15th largest position. S Bank Fund Management Ltd’s holdings in Danaher were worth $11,979,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in DHR. JPL Wealth Management LLC purchased a new stake in shares of Danaher in the 3rd quarter worth about $25,000. Elevated Capital Advisors LLC purchased a new position in shares of Danaher during the fourth quarter valued at about $26,000. WFA of San Diego LLC purchased a new position in shares of Danaher during the second quarter valued at about $26,000. ANTIPODES PARTNERS Ltd bought a new position in Danaher in the third quarter worth about $27,000. Finally, Financial Life Planners purchased a new stake in Danaher in the third quarter worth about $32,000. Institutional investors own 79.05% of the company’s stock.
Insiders Place Their Bets
In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president directly owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 10.80% of the stock is currently owned by insiders.
Danaher Stock Performance
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. Danaher’s revenue was up 3.7% compared to the same quarter last year. During the same period last year, the business earned $1.88 EPS. Sell-side analysts anticipate that Danaher Corporation will post 8.43 EPS for the current fiscal year.
Danaher Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is 30.95%.
Analyst Ratings Changes
DHR has been the topic of a number of research analyst reports. TD Cowen reduced their target price on Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. JPMorgan Chase & Co. dropped their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Guggenheim decreased their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. KeyCorp reissued an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Eighteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $240.70.
Check Out Our Latest Stock Analysis on Danaher
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
